BRD2 and Infertility: However, live birth is increasingly being recognized as the standard clinical end-target measurement to estimate the success of infertility treatments [22,23,24], particularly considering the potential effects of different FSH preparations with distinct glycosylation patterns on oocyte quality [25,26].